Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,592
Total Claims
$548K
Drug Cost
1,659
Beneficiaries
$330
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+28%
Opioid rate vs peers
58.7% vs 45.9% avg
-32%
Cost per patient vs peers
$330 vs $483 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
58.7%
Opioid Rate
9,747
Opioid Claims
$391K
Opioid Cost
11.1%
Long-Acting Rate
This provider's opioid prescribing rate of 58.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 16,212 claims · $345K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 5,022 | $119K |
| Oxycodone Hcl | 142 | $113K |
| Oxycodone Hcl/Acetaminophen | 2,210 | $67K |
| Fentanyl | 441 | $44K |
| Naloxegol Oxalate | 67 | $28K |
| Gabapentin | 1,730 | $21K |
| Diclofenac Sodium | 377 | $13K |
| Oxycodone Myristate | 20 | $8,611 |
| Oxycodone Hcl | 337 | $8,599 |
| Tramadol Hcl | 904 | $8,148 |
| Tizanidine Hcl | 870 | $7,774 |
| Pregabalin | 454 | $7,336 |
| Cyclobenzaprine Hcl | 763 | $7,217 |
| Vortioxetine Hydrobromide | 11 | $5,540 |
| Lidocaine | 32 | $5,271 |
Prescribing Profile
50
Unique Drugs
21.0
Anomaly Score
Patient Profile
70
Avg Age
64%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About